futuuropen

Tdi-11861 (a fast-acting male contraceptive) approved for human clinical trials by the end of 2026?

Name: Tdi-11861 (a fast-acting male contraceptive) approved for human clinical trials by the end of 2026?
Creator: Forecast Insight

OUI

—

NON

—

Fournisseur: Reproductive Health

Liquidity: $273.547

mis à jour: May 7, 2026, 06:01 AM

Commentaires (0)

Connectez-vous pour commenter. Connexion

Aucun résultat